James F. Oliviero III, CEO, President and Director at Checkpoint Therapeutics, Inc. (CKPT), sold 14,950 shares at $2.06 ($12K) on 2024-02-28, disclosed to the SEC on 2024-03-01.
Open-market sale of $12k CKPT by CEO, President and Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 9,056 | $0 | 0.0% |
| 2 | $2.06 | 5,894 | $12K | 100.0% |
| Total | $0.81 avg | 14,950 | $12K | 100% |
| Filing → |
| CKPT | SELL | 2024-12-20 | $6.1M | — | Filing → |
| CKPT | SELL | 2024-06-28 | $101K | — | Filing → |
| CKPT | SELL | 2024-02-02 | $24K | — | Filing → |